Myasthenic crisis in the setting of Coronavirus Disease 2019 (COVID-19)

• A patient with Myasthenia Gravis (MG) on immunosuppressive therapy with underlying respiratory compromise may be more susceptible to infection with COVID-19 or severe manifestations of the virus. • It is theorized that patients with MG may be more vulnerable to bacterial and viral infections, due...

Full description

Saved in:
Bibliographic Details
Published in:J Clin Anesth
Main Authors: Salik, Irim, Rodhouse, Heather Brosnan, Barst, Samuel
Format: Artigo
Language:Inglês
Published: Elsevier 2020
Subjects:
Correspondence
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7368911/
https://ncbi.nlm.nih.gov/pubmed/32707518
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jclinane.2020.110001
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items